StonvexLoading…
StonvexStonvexStonvexCore line items from RLAY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $15.36M | $10.01M | $25.55M | $1.38M |
Operating Income | $-302.74M | $-372.47M | $-373.00M | $-299.27M |
Net Income | $-276.48M | $-337.71M | $-341.97M | $-290.51M |
EPS (Diluted) | $-1.61 | $-2.36 | $-2.79 | $-2.59 |
Total Assets | $621.33M | $871.30M | $843.98M | $1.10B |
Total Liabilities | $54.27M | $93.50M | $91.98M | $149.55M |
Cash & Equivalents | $84.02M | $124.29M | $143.74M | $151.79M |
Free Cash Flow OCF − CapEx | $-235.87M | $-251.13M | $-304.44M | $-238.55M |
Shares Outstanding | 173.87M | 167.76M | 127.46M | 121.11M |